The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Topoisomerase II alpha gene status, HER2, and microtubule-associated protein tau as predictors of pathologic complete response after neoadjuvant chemotherapy.
Agust Barnadas
No relevant relationships to disclose
Ariadna Tibau Martorell
No relevant relationships to disclose
Laura Lopez Vilaro
No relevant relationships to disclose
Daniel Escuin
No relevant relationships to disclose
M Carmen Alonso
No relevant relationships to disclose
Belen Ojeda
No relevant relationships to disclose
Teresa Ramon y Cajal
No relevant relationships to disclose
M Josefa Fuentes
No relevant relationships to disclose
Jose Ignacio Perez Garcia
No relevant relationships to disclose
Barbara Garcia Valdecasas
No relevant relationships to disclose
Montserrat Clotet
No relevant relationships to disclose
M Sofia Torrubia
No relevant relationships to disclose
Ignasi Gich
No relevant relationships to disclose
Enrique Lerma
No relevant relationships to disclose